SCHEMBL17091597

SCHEMBL17091597

Oc1cccc2ccc(-c3ccc(-c4nnn[nH]4)cc3)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 2/20 0.41
▸ PLAU P00749 1/20 0.41
▸ NCF1 P14598 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ PDE4D Q08499 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ SOS2 Q07890 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PIM1 P11309 1/20 0.37
▸ PARP1 P09874 7/20 0.37
▸ MMP2 P08253 1/20 0.36
▸ CHRM1 P11229 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17091595 0.76 KMT2A (0.38) METAP2KDM4EKMT2APARP1TNKS
SCHEMBL29729655 0.75 PARP1 (0.58) METAP2PLAUNCF1ALDH1A1HPGD
SCHEMBL564494 0.75 PARP1 (0.58) METAP2PLAUNCF1ALDH1A1HPGD
SCHEMBL10049513 0.74 PLAU (0.58) METAP2PLAUNCF1ALDH1A1HPGD
SCHEMBL6662996 0.74 METAP2 (0.49) METAP2PLAUNCF1ALDH1A1HPGD
SCHEMBL29040616 0.74 PARP1 (0.57) METAP2PLAUNCF1ALDH1A1HPGD
SCHEMBL6431677 0.74 PARP1 (0.57) METAP2PLAUNCF1ALDH1A1HPGD
SCHEMBL30457867 0.74 PARP1 (0.57) METAP2PLAUNCF1ALDH1A1HPGD
Lithium SCHEMBL17924084 0.74 PARP1 (0.57) METAP2PLAUNCF1ALDH1A1HPGD
SCHEMBL29040612 0.74 PARP1 (0.57) METAP2PLAUNCF1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2624695-B1 NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS NIVALIS THERAPEUTICS INC (US) 2015-09-23 — — EP claimed
Send feedback